MochaTrade is a very early-stage startup from Y Combinator's Spring 2026 batch, focused on offering INR-margined perpetual-style trading of US stocks to Indian users. As of late 2026, the company operates with a small team and recently raised an undisclosed pre-seed round earmarked for building out its trading engine and regulatory infrastructure 3 sources. While it has been running a waitlist and controlled beta with no public user or revenue figures confirmed indianstartuptimes.com, the found
This forecast was maintained at 15% because it remains consistent with the broader view that while early-stage scaling takes time, a 5-year horizon gives the platform a viable window to navigate headwinds.
MochaTrade, operated in India by ALSD Technologies Pvt Ltd, offers highly leveraged INR-margined perpetual contracts on US stocks, indices, and commodities, potentially hedged on offshore venues like Binance futures and Hyperliquid 3 sources. The company claims its domestic INR wrapper avoids FEMA/LRS rules mochatrade.com and has registered with FIU-IND as a Virtual Digital Asset Service Provider (REID VA00049752) mochatrade.com. This registered domestic status
Set against related questions, this was slightly raised from 20% to 22% to fully account for both the administrative shutdown risk and the smaller chance of a severe criminal crackdown over the 5-year horizon.
MochaTrade operates in a significant regulatory grey area by offering INR-margined perpetual-style products for US stocks, which are reportedly hedged on offshore crypto venues like Binance Futures mochatrade.com. This business model creates genuine legal exposure under India's Securities Contracts (Regulation) Act (SCRA), the Foreign Exchange Management Act (FEMA), and the Prevention of Money Laundering Act (PMLA) 2 sources. Despite these risks, the probability of a founder or senior executive
Set against related questions, this estimate was held at 5%, as the 5-year timeline leaves room for severe regulatory escalation while standard administrative actions remain much more likely.
Ask a followup
Sign in to run · $20 free credit, no card · every claim cited